GLI1 and hepatocellular carcinoma: Furthermore, HCC cell lines were treated with DMSO (control), sorafenib, GANT61, or sorafenib and GANT61 combination for 24 h, and expression of Ptch1, Gli1, Shh and CD44 was examined.